Philips agrees to buy Spectranetics Corp for 1.9 billion euros
@Philips agrees to buy #Spectranetics Corp for 1.9 billion euros
News Hour:
Dutch healthcare company Philips has agreed to buy U.S.-based Spectranetics Corp, a maker of devices to treat heart disease, for 1.9 billion euros ($2.16 billion) including debt, as it expands its image-guided therapy business.
Spectranetics uses techniques including lasers and tiny drug-covered balloons to clean the insides of veins and arteries that have become clogged due to heart…
View On WordPress











